The Brazilian Health Regulatory Agency received a temporary authorization request for the Chinese immunizer Sinopharm. It has not undergone clinical trials in Brazil but has been tested in countries like the United Arab Emirates, Egypt, Argentina, and Peru.
LATEST NEWS
- IMF forecasts economic growth in Kuwait
- Syria seeks World Bank support for agriculture
- Brazil’s consumption of imports hits 20-year high
- Flamengo defeated by PSG in Qatar tournament
- Flavors of Brazil on Egyptian screens
- UAE opens market to Brazil’s bovine embryos
- Jordanian company stands out in female employment
- Brazil’s franchising sector grows 9.1%
